Systemic Lupus Erythematosus Clinical Trials in Miami, Florida

4 studies are recruiting for systemic lupus erythematosus in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

    The primary objective of this trial is to evaluate the efficacy and safety of FT819, comprised of allogeneic T cells that express a CD19-targeted CAR, following bendamustine administration in participants with refractory moderate-to-severe lupus nephritis, as assessed by the proportion of participa…

    Stage
    Phase 2
    Ages
    12 to 70
    Site
    Miami Dermatology and Laser Research, Miami, Florida
    Locations
    12 in total
    Run by
    Fate Therapeutics

    See if you can join NCT07570862 on ClinicalTrials.gov

  2. A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

    The purpose of the SUNFLOWER study is to describe clinical outcomes, including DORIS remission, achieved following the initiation of anifrolumab 120 mg SC once weekly (QW) as add-on therapy to an anti-malarial, with or without GC; in patients not in LLDAS at enrolment. Patients will be naïve to any…

    Stage
    Phase 3
    Ages
    18 to 70
    Site
    Research Site, Miami, Florida
    Locations
    107 in total
    Run by
    AstraZeneca

    See if you can join NCT07430306 on ClinicalTrials.gov

  3. A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

    The purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of moderate to severe disease activity.

    Stage
    Phase 3
    Ages
    16 and older
    Site
    Sl0044 50747, Miami, Florida
    Locations
    242 in total
    Run by
    UCB Biopharma SRL

    See if you can join NCT06617325 on ClinicalTrials.gov

  4. A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

    The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythematosus (SLE) with nephritis (Subprotocol A) and to assess the safety and tolerability of subcutaneous (SC) blinatumomab in adult participants with activ…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Vitaly Clinical Research, Miami, Florida
    Locations
    58 in total
    Run by
    Amgen

    See if you can join NCT06570798 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.